Past medical history: Jaw fracture as above. Migraine headaches. Mild reactive airway disease: 1 episode, not on chronic medication.
Past surgical history: None.
Family history: Both parents are alive and well. He has a younger sister, age 5, who has reactive airway disease. His paternal grandmother died secondary to complications of a liver transplant performed for liver failure due to hepatitis C. His maternal grandmother has rheumatoid arthritis. His maternal grandfather has unspecified "heart disease," possibly a history of myocardial infarction.
Social history:
The patient lives with his parents and sister in an apartment building. His mother works for a nonprofit organization, and his father is a photojournalist. He loves school and is an excellent student, artist, and violinist. He loves his cat.
Allergies: None known.
Medications: None prior to chemotherapy; none since chemotherapy has been complete.
Relevant Review of Symptoms
Ears, eyes, nose, and throat: Significant trismus persists but is well tolerated as he can now eat well. Speech is not negatively effected.
General: He is back in school and feels almost entirely well, but he still fatigues easily.
Gastrointestinal:
Appetite is now normal.
Neurological: No recent migraine headaches; the paresthesias and weakness of his fingers have resolved.
Physical Examinations
Lean but well-looking preadolescent male. Normal vital signs.
Muscle strength: Symmetrical, 4+/4+. No Romberg sign.
Gait: Normal, deep tendon reflexes absent at ankle and knees. Impression: The patient is an 11-year-old boy with a localized synovial sarcoma of the left jaw.
Plan:
The patient was treated with multiagent chemotherapy: vincristine, actinomycin-D and cyclophosphamide, and ifosfamide, vincristine, and doxorubicin. Local control consisted of radiation therapy and surgery.
Course:
The patient received a total of 9 cycles of chemotherapy. Although his clinical response to therapy was excellent, characterized by diminished jaw swelling and less pain, on imaging, the best response achieved was less than a partial response. He was treated with radiation therapy to the lesion, followed by resection and continued chemotherapy. The pathology after radiation and surgery demonstrated close but clear margins and poor necrosis.
During the course of treatment, the patient had several episodes of admission for fever and neutropenia. During radiation therapy, he required enteral feedings via a percutaneous gastrostomy due to significant mucositis and anorexia. He developed moderately severe neuropathy due to vincristine that clinically resolved after therapy was completed. The neuropathy was particularly troubling to the patient because he plays violin, and the paresthesias impaired his ability to play. After surgery and radiation, he developed significant trismus for which he is still undergoing physical therapy. Three months after chemotherapy was complete, he developed a local abscess at the site of surgery with Capnocytophaga that responded completely to antibacterial therapy and incision and drainage. 
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The patient was treated with multiagent chemotherapy consisting of 3 cycles of vincristine, actinomycin-D, and cyclophosphamide followed by 6 cycles of ifosfamide, vincristine, and doxorubicin. Although his clinical response to therapy was excellent, characterized by diminished jaw swelling and less pain, on imaging, the best response achieved was less than a partial response. He was treated with radiation therapy to the lesion, followed by resection and continued chemotherapy. The pathology after radiation and surgery demonstrated close, but clear, margins and poor necrosis.
During the course of treatment, the patient had several episodes of admission for fever and neutropenia. During radiation therapy, he required enteral feedings via a percutaneous gastrostomy. He developed moderate to severe neuropathy due to vincristine that resolved after therapy was completed. After surgery and radiation, he developed significant trismus that responded partly to acupuncture and massage.
Soft tissue sarcomas are cancers that develop in muscle or other soft tissues of the body. In children, the most common form of soft tissue sarcoma is rhabdomyosarcoma. The nonrhabdomyosarcomas are a group of soft tissue cancers that account for only 3% of childhood cancers; in this small group, synovial sarcomas are the most common. In adults, synovial sarcomas comprise close to 10% of sarcomas.
1 Thus, much of the information we have about this rare tumor is derived from the adult experience and literature. Synovial sarcomas may arise anywhere in the body. They are generally slow growing but may be very aggressive locally. Specific cytogenetic abnormalities have been associated with synovial sarcoma: more than 90% of the tumors have a t(X; 18) translocation. This translocation involves the gene SYT (at 18q11) and the SSX1 or SSX2 gene on the X chromosome (at Xp11). These genes are transcription regulators. There is some evidence to suggest that patients whose tumors demonstrate the SYT-SSX2 translocation have improved 5-year survival as compared with those patients with the SYT-SSX1 translocation. 2, 3 The natural history of synovial sarcoma includes a propensity for local recurrence as well as the development of pulmonary metastases. Good prognosis is inversely related to metastases at diagnosis, size >5 cm at diagnosis, inability to perform a complete excision, and the ability to surgically remove the tumor. 1,4 Children generally have a better prognosis than adults. Head and neck synovial sarcomas have a poorer prognosis than those involving the extremities, with survival rates reported to be between 47% and 82%.
Appropriate treatment of synovial sarcoma requires surgical resection. When complete resection cannot be achieved without significant morbidity, radiation therapy is indicated for close or positive surgical margins. In a retrospective review of 219 patients
